Achieve Safe & Targeted In Vivo Delivery of Payloads with Clarity in Regulations & Appropriate Models to Advance the Next Frontier of In Vivo Editing from Research to Clinic
July 9-11, 2024 | Boston, MA
Welcome to the 3rd In Vivo Cell Engineering & Gene Editing Summit!
As promising pre-clinical and proof of concept results continue to emerge, the pivotal shift from the βdreamβ of in vivo cell engineering and gene editing is rapidly becoming a reality as numerous companies push towards the clinic. Uniting key thought-leading experts, the 3rd In Vivo Cell Engineering & Gene Editing Summit will be a uniquely positioned, must-attend gathering, delving into all facets of development to spearhead in vivo as the frontier of cell and gene therapies.
Crafted in collaboration with industry titans such as Capstan Therapeutics, Editas Medicine, NanoCell Therapeutics, Carisma Therapeutics, Mustang Bio, iECURE, and many others, our newly curated agenda for 2024 promises unparalleled insights:
Join us this July to glean invaluable knowledge from our world-class speaker faculty, offering an exclusive dive into how experts plan to stay ahead of the curve and shape the future of cell and gene therapy in the years ahead.
Key Highlights
Download the Full Agenda for More Information on:
-
-
-
- 15+ In Vivo Expert Speakers
- 2 Interactive Deep-Dive Workshops
- 8+ Hours of Industry Networking
- & Much More!
-
-